Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial. (Record no. 29663172)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02182 a2200661 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518035942.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201910s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 2352-3026 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1016/S2352-3026(19)30029-8 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Garcia-Manero, Guillermo |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20191030 |
| 245 00 - TITLE STATEMENT | |
| Title | Guadecitabine (SGI-110) in patients with intermediate or high-risk myelodysplastic syndromes: phase 2 results from a multicentre, open-label, randomised, phase 1/2 trial. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | The Lancet. Haematology |
| Date of publication, distribution, etc. | Jun 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | e317-e327 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adolescent |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Azacitidine |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Dose-Response Relationship, Drug |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Myelodysplastic Syndromes |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neutropenia |
| General subdivision | etiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Severity of Illness Index |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Survival Rate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Thrombocytopenia |
| General subdivision | etiology |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Young Adult |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Roboz, Gail |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Walsh, Katherine |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kantarjian, Hagop |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ritchie, Ellen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kropf, Patricia |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | O'Connell, Casey |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tibes, Raoul |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lunin, Scott |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rosenblat, Todd |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Yee, Karen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Stock, Wendy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Griffiths, Elizabeth |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Mace, Joseph |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Podoltsev, Nikolai |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Berdeja, Jesus |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jabbour, Elias |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Issa, Jean-Pierre J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hao, Yong |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Keer, Harold N |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Azab, Mohammad |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Savona, Michael R |
| 773 0# - HOST ITEM ENTRY | |
| Title | The Lancet. Haematology |
| Related parts | vol. 6 |
| -- | no. 6 |
| -- | p. e317-e327 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1016/S2352-3026(19)30029-8">https://doi.org/10.1016/S2352-3026(19)30029-8</a> |
| Public note | Available from publisher's website |
No items available.